Journal of Antimicrobial Chemotherapy, Vol 40, 161-170, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
D Landman and JM Quale
The incidence of nosocomial enterococcal infection has increased steadily
over the past two decades. The treatment of patients with enterococcal
infection has been complicated by the emergence of strains possessing high
level resistance to aminoglycosides, penicillins and, most recently,
glycopeptides. Several recent studies have evaluated alternative
antimicrobial agents for use against strains resistant to some or all
standard agents. In this report, we review the therapeutic options for the
management of antibiotic-resistant enterococcal infection.
REVIEWS
Management of infections due to resistant enterococci: a review of therapeutic options
Section of Infectious Diseases(IIIE), Department of Veterans Affairs Medical Center at Brooklyn, NY 11209, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. S. Hummel, C. Hertel, W. H. Holzapfel, and C. M. A. P. Franz Antibiotic Resistances of Starter and Probiotic Strains of Lactic Acid Bacteria Appl. Envir. Microbiol., February 1, 2007; 73(3): 730 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zarrilli, M.-F. Tripodi, A. Di Popolo, R. Fortunato, M. Bagattini, M. Crispino, A. Florio, M. Triassi, and R. Utili Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy J. Antimicrob. Chemother., November 1, 2005; 56(5): 827 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Andrews, J. P. Ashby, G. Jevons, and R. Wise Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodology J. Antimicrob. Chemother., September 1, 2003; 52(3): 526 - 527. [Full Text] [PDF]
|
|
|
|
|
|
A. Hallgren, B. Saeedi, M. Nilsson, H.-J. Monstein, B. Isaksson, H. Hanberger, and L. E. Nilsson Genetic relatedness among Enterococcus faecalis with transposon-mediated high-level gentamicin resistance in Swedish intensive care units J. Antimicrob. Chemother., August 1, 2003; 52(2): 162 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. L. Low, N. S. Jakubovics, J. C. Flatman, H. F. Jenkinson, and A. W. Smith Manganese-dependent regulation of the endocarditis-associated virulence factor EfaA of Enterococcus faecalis J. Med. Microbiol., February 1, 2003; 52(2): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cotter and C. C. Adley Comparison and Evaluation of Antimicrobial Susceptibility Testing of Enterococci Performed in Accordance with Six National Committee Standardized Disk Diffusion Procedures J. Clin. Microbiol., October 1, 2001; 39(10): 3753 - 3756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. A. P. Franz, A. B. Muscholl-Silberhorn, N. M. K. Yousif, M. Vancanneyt, J. Swings, and W. H. Holzapfel Incidence of Virulence Factors and Antibiotic Resistance among Enterococci Isolated from Food Appl. Envir. Microbiol., September 1, 2001; 67(9): 4385 - 4389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cotter and C. C. Adley Ciprofloxacin susceptibility testing of enterococcal urinary isolates in accordance with BSAC guidelines J. Antimicrob. Chemother., August 1, 2001; 48(2): 324 - 325. [Full Text] [PDF]
|
|
|
|
|
|
A. Verma, A. Dhawan, J. Philpott-Howard, M. Rela, N. Heaton, G. M. Vergani, and J. Wade Glycopeptide-resistant Enterococcus faecium infections in paediatric liver transplant recipients: safety and clinical efficacy of quinupristin/dalfopristin J. Antimicrob. Chemother., January 1, 2001; 47(1): 105 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. O. Onyeji, D. P. Nicolau, C. H. Nightingale, and L. Bow Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection J. Antimicrob. Chemother., September 1, 2000; 46(3): 429 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Catalano, P. F. Hahn, D. C. Hooper, and P. R. Mueller Efficacy of Percutaneous Abscess Drainage in Patients with Vancomycin-Resistant Enterococci Am. J. Roentgenol., August 1, 2000; 175(2): 533 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. S. Nelson, K. F. McGregor, A. R. Brown, S. G. B. Amyes, and H.-K. Young Isolation and Characterization of Glycopeptide-Resistant Enterococci from Hospitalized Patients over a 30-Month Period J. Clin. Microbiol., June 1, 2000; 38(6): 2112 - 2116. [Abstract] [Full Text]
|
|
|
|
|
|
R. C. Moellering, P. K. Linden, J. Reinhardt, E. A. Blumberg, F. Bompart, and G.H. Talbot The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium J. Antimicrob. Chemother., August 1, 1999; 44(2): 251 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Zelenitsky, B. Booker, N. Laing, J. A. Karlowsky, D. J. Hoban, and G. G. Zhanel Synergy of an Investigational Glycopeptide, LY333328, with Once-Daily Gentamicin against Vancomycin-Resistant Enterococcus faecium in a Multiple-Dose, In Vitro Pharmacodynamic Model Antimicrob. Agents Chemother., March 1, 1999; 43(3): 592 - 597. [Abstract] [Full Text]
|
|
|
|
|
|
F. Allerberger and I. Klare In-vitro activity of fosfomycin against vancomycin-resistant enterococci J. Antimicrob. Chemother., February 1, 1999; 43(2): 211 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Schoonmaker, L. H. Bopp, A. L. Baltch, R. P. Smith, M. E. Rafferty, and M. George Genetic Analysis of Multiple Vancomycin-Resistant Enterococcus Isolates Obtained Serially from Two Long-Term-Care Patients J. Clin. Microbiol., July 1, 1998; 36(7): 2105 - 2108. [Abstract] [Full Text]
|
|